AK

Anupama Kadalath Nalledath

Active Director Director DIN 08511993
DIN 08511993 First appointment Jul 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Anupama Kadalath Nalledath

Data last updated:

Anupama Kadalath Nalledath is a Director at Crestmed Pharmaceuticals Private Limited (since 2019). The company operates in Pharma.

DIN 08511993
Primary Designation Director
Industry Pharma
First Appointment 16 Jul 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jul 20192019Active

Board colleagues of Anupama Kadalath Nalledath

Directorship timeline

Open interactive timeline →
Crestmed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anupama Kadalath Nalledath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anupama Kadalath Nalledath

Anupama Kadalath Nalledath currently holds 1 directorship: Crestmed Pharmaceuticals Private Limited (Director, since 16 Jul 2019).

Anupama Kadalath Nalledath was first appointed on 16 Jul 2019 as Director at Crestmed Pharmaceuticals Private Limited.

The current boards of Anupama Kadalath Nalledath's companies include Ashy John (Crestmed Pharmaceuticals Private Limited), Krishna Kumar Sadasivan Pillai (Crestmed Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available